Article

Test could aid detection of AMD

According to a Canadian study, computer-based methods for evaluating the eye's ability to distinguish object details and shape in patients with age-related macular degeneration (AMD) could provide a more accurate assessment of the effectiveness of eye surgery and vision rehabilitation.

According to a Canadian study, computer-based methods for evaluating the eye's ability to distinguish object details and shape in patients with age-related macular degeneration (AMD) could provide a more accurate assessment of the effectiveness of eye surgery and vision rehabilitation.

Authors of the study incorporated four known features to improve visual acuity in their computer-based method: high contrast; white optotypes (symbols, letters, or numbers used in vision testing) on a black background to reduce intraocular scatter; proportional layout to reduce the effect of crowding; and multiple optotypes to minimize the effects of fixation instability and to maximize the likelihood of optotype detection.

After experimenting authors concluded that a multiple-optotype, reversed-polarity test is most effective in estimating a patient's optimal visual acuity at baseline before vision rehabilitation interventions or surgery.

"People with AMD rarely read or view things under optimal conditions, so this is not a test of how well they see in daily life," said study author, Esther G. González "This test is designed to give vision rehabilitation practitioners a measure of the best visual acuity a person is capable of and in this sense it could be a useful tool for assessing rehabilitation progress."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.